Lupartumab
Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
Product Specifications
CAS Number
1640971-88-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximately 150 kDa.
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
ADC Antibody
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
